Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Maria Skłodowska-Curie National Research Institute of Oncology- Warsaw

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Maria Skłodowska-Curie National Research Institute of Oncology is one of Poland’s leading centers for cancer research, treatment, and education. Named after the renowned scientist Marie Skłodowska-Curie, the institute plays a vital role in advancing oncology through innovative research and high-quality clinical care. It operates major branches in Warsaw, Gliwice, and Kraków, offering comprehensive cancer diagnosis, therapy, and rehabilitation services. The institute is also deeply involved in clinical trials, contributing to the development of new therapeutic approaches and improving patient outcomes. In addition to its medical services, it serves as a key academic hub, training healthcare professionals and researchers in oncology-related fields. By integrating scientific research with patient-centered care, the institute significantly contributes to national and international efforts to combat cancer.

Source: Trial-derived.
18Total Trials
Source: Trial-derived.
10Recruiting Trials
Source: Trial-derived.
13Active Trials
Source: Trial-derived.
3Completed Trials
Source: Trial-derived.
28Unique Conditions
Source: Trial-derived.
13Unique Sponsors

Conditions

Source: Trial-derived. Head and Neck Cancer (2)Source: Trial-derived. Ventricular Tachycardia (2)Source: Trial-derived. Acceptance and Commitment Therapy (1)Source: Trial-derived. Adenoid Cystic Carcinoma (1)Source: Trial-derived. Adrenocortical Carcinoma (1)Source: Trial-derived. B-cell Non-Hodgkin Lymphoma (1)Source: Trial-derived. Brain Metastases From Non-small Cell Lung Cancer (NSCLC) (1)Source: Trial-derived. Colonic Neoplasms (1)

Sponsors

Source: Trial-derived. Maria Sklodowska-Curie National Research Institute of Oncology (11)Source: Trial-derived. Advanced Accelerator Applications (1)Source: Trial-derived. Biostat Sp. z o.o. (1)Source: Trial-derived. Bristol-Myers Squibb (1)Source: Trial-derived. Hoffmann-La Roche (1)Source: Trial-derived. Leszek Giec Upper Silesian Medical Center of the Medical University of Silesia in Katowice, Poland (1)Source: Trial-derived. MacroGenics (1)Source: Trial-derived. M.D. Anderson Cancer Center (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease testing